Toulouse University Hospital
🇫🇷France
Clinical Trials
753
Active:14
Completed:381
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:16
Phase 2:49
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (534 trials with phase data)• Click on a phase to view related trials
Not Applicable
409 (76.6%)Phase 2
49 (9.2%)Phase 4
34 (6.4%)Phase 3
25 (4.7%)Phase 1
16 (3.0%)Early Phase 1
1 (0.2%)Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder: A Pilot Study
Not Applicable
Not yet recruiting
- Conditions
- Infusion of Ketamine in Severe Borderline Personality DisorderBorderline Personality Disorder (BPD)
- Interventions
- Drug: IV Ketamine (0.5 mg/kg) Infusion - Two Doses Administered 24 Hours Apart for Severe Borderline Personality Disorder
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 38
- Registration Number
- NCT07099534
- Locations
- 🇫🇷
Toulouse Purpan University Hospital, Head of Psychiatry Clinic in the UF3 department, Toulouse, France
Home-based Cognitive Strategy Training for Daily Living in Adults With Chronic Stroke
Not Applicable
Not yet recruiting
- Conditions
- StrokeCerebrovascular Disorders
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 18
- Registration Number
- NCT07084025
Non-interventional Study Exploring the Composition of the Valvular Microbiota of Patients Undergoing Cardiac Surgery
Not Applicable
Not yet recruiting
- Conditions
- ValvulopathyCardiac SurgeryMicrobiota
- Interventions
- Biological: Take 1 ml of bloodBiological: DNA sequencingProcedure: Valve collection (healthcare waste)Other: Collection of serious post-operative complications
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 200
- Registration Number
- NCT07075601
- Locations
- 🇫🇷
Rangueil Hospital, Toulouse, France
Chrono-restricted Diet and Physical Activity as a New Preventive Strategy for Sarcopenia in Postmenopausal Women With Obesity and Type 2 Diabetes
Not Applicable
Not yet recruiting
- Conditions
- ObesitySarcopeniaPost MenopauseType 2 DiabetesCircadian Clock
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 45
- Registration Number
- NCT07075133
- Locations
- 🇫🇷
Rangueil Hospital, Toulouse, France
Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment
Not Applicable
Active, not recruiting
- Conditions
- HIV (Human Immunodeficiency Virus)
- First Posted Date
- 2025-07-14
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 30
- Registration Number
- NCT07062614
- Locations
- 🇫🇷
Infectious and Tropical Diseases Department, Purpan University Hospital, Toulouse Place du Docteur Baylac, Toulouse, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 150
- Next
News
Lixisenatide Shows Promise in Slowing Parkinson's Disease Progression in Phase 2 Trial
A Phase 2 trial of Sanofi's lixisenatide demonstrated the GLP-1 agonist's potential to halt motor symptom progression in Parkinson's disease patients over 12 months.